These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 37615792)
1. Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients. Isiklar AD; Aliyeva L; Yesilyurt A; Soyder A; Basaran G Breast Cancer Res Treat; 2023 Nov; 202(2):297-304. PubMed ID: 37615792 [TBL] [Abstract][Full Text] [Related]
2. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Ni M; Wang F; Yang A; Shao Q; Xue C; Xia W; Xu F; Lin X; Huang J; Bi X; Hong R; Chen M; Zheng Q; Jiang K; Xie X; Tang J; Wang X; Yuan Z; Wang S; Shi Y; An X Cancer Med; 2023 Jun; 12(12):13019-13030. PubMed ID: 37096751 [TBL] [Abstract][Full Text] [Related]
3. Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge. Bono M; Fanale D; Incorvaia L; Cancelliere D; Fiorino A; Calò V; Dimino A; Filorizzo C; Corsini LR; Brando C; Madonia G; Cucinella A; Scalia R; Barraco N; Guadagni F; Pedone E; Badalamenti G; Russo A; Bazan V ESMO Open; 2021 Aug; 6(4):100235. PubMed ID: 34371384 [TBL] [Abstract][Full Text] [Related]
4. Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Tuncer SB; Celik B; Erciyas SK; Erdogan OS; Gültaslar BK; Odemis DA; Avsar M; Sen F; Saip PM; Yazici H Pathol Res Pract; 2024 Feb; 254():155075. PubMed ID: 38219492 [TBL] [Abstract][Full Text] [Related]
5. Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis. Sandoval RL; Leite ACR; Barbalho DM; Assad DX; Barroso R; Polidorio N; Dos Anjos CH; de Miranda AD; Ferreira ACSM; Fernandes GDS; Achatz MI PLoS One; 2021; 16(2):e0247363. PubMed ID: 33606809 [TBL] [Abstract][Full Text] [Related]
6. Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review. Pavlovica K; Irmejs A; Noukas M; Palover M; Kals M; Tonisson N; Metspalu A; Gronwald J; Lubinski J; Murmane D; Kalnina A; Loza P; Maksimenko J; Trofimovics G; Subatniece S; Daneberga Z; Miklasevics E; Gardovskis J Eur J Med Genet; 2022 May; 65(5):104477. PubMed ID: 35314380 [TBL] [Abstract][Full Text] [Related]
7. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes. Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516 [TBL] [Abstract][Full Text] [Related]
8. Study of the Genetic Variants in Solano AR; Mele PG; Jalil FS; Liria NC; Podesta EJ; Gutiérrez LG Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072659 [TBL] [Abstract][Full Text] [Related]
9. Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation-Negative Breast Cancer. Park JS; Shin S; Lee YJ; Lee ST; Nam EJ; Han JW; Lee SH; Kim TI; Park HS Cancer Res Treat; 2022 Oct; 54(4):1099-1110. PubMed ID: 34793666 [TBL] [Abstract][Full Text] [Related]
10. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626 [TBL] [Abstract][Full Text] [Related]
11. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Buys SS; Sandbach JF; Gammon A; Patel G; Kidd J; Brown KL; Sharma L; Saam J; Lancaster J; Daly MB Cancer; 2017 May; 123(10):1721-1730. PubMed ID: 28085182 [TBL] [Abstract][Full Text] [Related]
12. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis. Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767 [TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity. Bu R; Siraj AK; Al-Rasheed M; Iqbal K; Azam S; Qadri Z; Haqawi W; Tulbah A; Al-Dayel F; Almalik O; Al-Kuraya KS Sci Rep; 2023 Nov; 13(1):20924. PubMed ID: 38017116 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Su Y; Yao Q; Xu Y; Yu C; Zhang J; Wang Q; Li J; Shi D; Yu B; Zeng Y; Zhu X; Bai Q; Zhou X Front Genet; 2021; 12():674094. PubMed ID: 34917121 [No Abstract] [Full Text] [Related]
16. Identification of a novel pathogenic variant in Laraqui A; Cavaillé M; Uhrhammer N; ElBiad O; Bidet Y; El Rhaffouli H; El Anaz H; Rahali DM; Kouach J; Guelzim K; Badaoui B; AlBouzidi A; Oukabli M; Tanz R; Sbitti Y; Ichou M; Ennibi K; Sekhsokh Y; Bignon YJ J Genomics; 2021; 9():43-54. PubMed ID: 34646395 [TBL] [Abstract][Full Text] [Related]
17. Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system. Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH Gynecol Oncol; 2022 Dec; 167(3):467-475. PubMed ID: 36220669 [TBL] [Abstract][Full Text] [Related]
18. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients. Sabol RA; Ledet EM; Jaeger E; Hatton W; Moses M; Lankford A; Zaheria A; Barata P; Layton JL; Lewis BE; Sartor O Prostate; 2021 May; 81(7):427-432. PubMed ID: 33760238 [TBL] [Abstract][Full Text] [Related]
19. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1). Sorscher S; Ansley K; Delaney SD; Ramkissoon S Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686 [TBL] [Abstract][Full Text] [Related]
20. Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in Stegel V; Blatnik A; Škof E; Dragoš VŠ; Krajc M; Gregorič B; Škerl P; Strojnik K; Klančar G; Banjac M; Žgajnar J; Ravnik M; Novaković S Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]